United States· US:85551-125_51e3535b-dc11-abe8-e063-6394a90a0c61

Hydroxocobalamin

A medicinal product containing hydroxocobalamin, registered in United States by Xseer Pharmaceuticals.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedHydroxocobalaminATC—REGISTER NO.US:85551-125_51e3535b…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
HYDROXOCOBALAMIN
Manufacturer
Xseer Pharmaceuticals
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    85551-125-30
  • ndc11
    8555112530
    30 mL in 1 VIAL, GLASS (85551-125-30)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Hydroxocobalamin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hydroxocobalamin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Erycytol Depot
  • Belgium · Hydroxocobalamine Acetate Sterop
  • Cyprus · Articlox
  • Germany · Depogamma, Lophakomp-B 12-Depot
  • Denmark · Cohemin, Hydroxocobalamin Alternova
  • Spain · Hidroxocobalamina Basi, Megamilbedoce
  • Finland · Cohemin, Hydroxocobalamin G.L. Pharma
  • France · Dodecavit, Novobedouze
  • United Kingdom (Northern Ireland) · Cobalin-H, Hydroxocobalamin Accord Healthcare
  • Greece · Articlox
  • Ireland · Hydroxocobalamin G.L. Pharma, Hydroxy-Vit
  • Iceland · Cyanokit, Hydroxocobalamin G.L. Pharma
  • Italy · Neo Cytamen
  • Liechtenstein · Cyanokit
  • Malta · Articlox
  • Netherlands · Hydrocobamine, Hydroxocobalamine Focus Care
  • Norway · Cyanokit, Hydroxocobalamin Basi
  • Portugal · Hidroxocobalamina Basi
  • Sweden · Hydroxocobalamin Alternova, Hydroxocobalamin G.L. Pharma
  • Slovenia · Hidroksokobalamin Orion

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6140bda1-9098-47ba-b160-18b36a264fc7
GET /v1/drugs/6140bda1-9098-47ba-b160-18b36a264fc7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS",
  "source": "ndc",
  "strength": "1",
  "substance": "HYDROXOCOBALAMIN",
  "productndc": "85551-125",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": null,
  "marketing_category": "UNAPPROVED DRUG OTHER"
}

See everything about hydroxocobalamin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.